OR WAIT null SECS
Dr. Pritchard ?is the Vice President, Global Drug Development, with Celerion, Raleigh-Durham, North Carolina.
January 29, 2015
The developed markets of North America and Europe together saw approximately 81% of the Phase I trial share in 2013 which is a 6% increase from 2012. Trials